Ryna-12 S

Generic name:phenylephrine tannate and pyrilamine tannate
Dosage form: tablet, oral suspension
Drug class:Upper respiratory combinations

Medically reviewed by Drugs.com. Last updated on Nov 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Description

RYNA®-12 is an antihistamine/nasal decongestant combination available for oral administration as Tablets and as Suspension. Each tablet contains:

Phenylephrine Tannate 25 mg
Pyrilamine Tannate 60 mg
Other ingredients: corn starch, dibasic calcium phosphate, magnesium stearate, methylcellulose, polygalacturonic acid, talc.

Each 5 mL (one teaspoonful) of the pink-colored, natural strawberry-artificial currant flavored Suspension contains:
Phenylephrine Tannate 5 mg
Pyrilamine Tannate 30 mg

Other ingredients: benzoic acid, FD&C Red No. 3, flavors (natural and artificial), glycerin, kaolin, magnesium aluminum silicate, methylparaben, pectin, purified water, saccharin sodium, sucrose.

Clinical Pharmacology

RYNA®-12 combines the sympathomimetic decongestant effect of phenylephrine with the antihistaminic action of pyrilamine.

Indications and Usage

RYNA®-12 is indicated for symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.

Contraindications

RYNA®-12 is contraindicated for newborns, nursing mothers and patients sensitive to any of the ingredients or related compounds.

Warnings

Use with caution in patients